ام جوادددد

Injective is up 0.91% to $3.25 in 24 hours, outperforming a slightly declining Bitcoin, mainly due to the launch of the first regulated INJ futures contracts in the United States. This major advancement facilitates institutional access and begins a six-month countdown before potential eligibility for a spot ETF.
Main reason: Launch of regulated U.S. futures contracts on an exchange approved by the CFTC (Injective), enhancing institutional credibility and ETF prospects.